Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Aspirin/meprobamate

From Wikipedia, the free encyclopedia
(Redirected from Equagesic)
Aspirin/meprobamate
Combination of
AspirinNSAID
MeprobamateAnxiolytic
Clinical data
Trade namesEquagesic
AHFS/Drugs.comMicromedex Detailed Consumer Information
Routes of
administration
Oral
ATC code
Legal status
Legal status
Identifiers
CAS Number

Aspirin/meprobamate (trade name Equagesic /ˌɛkwəˈzɪk/) is a combination drug indicated for short-term pain treatment accompanied by tension or anxiety in patients with musculoskeletal disorders or tension headache.

Adverse effects

[edit]

Combinations

[edit]

There also appears to be a combination with ethoheptazine, an opioid analgesic.[1]

Problems

[edit]

Equagesic was discontinued in the United States, because of its possible toxic effects, specifically of meprobamate.[2][medical citation needed] It was credited with the sudden death of actor Bruce Lee in 1973. Lee suffered a fatal hypersensitive reaction to one of the prescription drug's ingredients while working in Hong Kong.[3][4]

References

[edit]
  1. "Equagesic". NetDoctor.co.uk. Archived from the original on 27 September 2007. Discontinued in the UK – March 2002
  2. "Meprobamate Tablets 400mg – Summary of Product Characteristics (SmPC) – (emc)". www.medicines.org.uk. Retrieved 2021-08-09.
  3. Chang R (7 June 2020). "Bruce Lee: The Mystery Surrounding the Martial Artist's Death". Biography. Retrieved 2021-08-09.
  4. "Bruce Lee". Bruce Lee. Retrieved 2021-08-09.